308 related articles for article (PubMed ID: 28418911)
1. Elevated serum level of pancreatic stone protein/regenerating protein (PSP/reg) is observed in diabetic kidney disease.
Li L; Jia D; Graf R; Yang J
Oncotarget; 2017 Jun; 8(24):38145-38151. PubMed ID: 28418911
[TBL] [Abstract][Full Text] [Related]
2. Pancreatic stone protein/regenerating protein (PSP/reg): a novel secreted protein up-regulated in type 2 diabetes mellitus.
Yang J; Li L; Raptis D; Li X; Li F; Chen B; He J; Graf R; Sun Z
Endocrine; 2015 Apr; 48(3):856-62. PubMed ID: 25234740
[TBL] [Abstract][Full Text] [Related]
3. Association of Serum PSP/REG I
Zhu H; Zhu X; Lin H; Liu D; Dai Y; Su X; Li L
J Diabetes Res; 2020; 2020():9787839. PubMed ID: 32309450
[TBL] [Abstract][Full Text] [Related]
4. Pancreatic stone protein: a marker of organ failure and outcome in ventilator-associated pneumonia.
Boeck L; Graf R; Eggimann P; Pargger H; Raptis DA; Smyrnios N; Thakkar N; Siegemund M; Rakic J; Tamm M; Stolz D
Chest; 2011 Oct; 140(4):925-932. PubMed ID: 21835904
[TBL] [Abstract][Full Text] [Related]
5. Serum and Urinary Progranulin in Diabetic Kidney Disease.
Nicoletto BB; Krolikowski TC; Crispim D; Canani LH
PLoS One; 2016; 11(10):e0165177. PubMed ID: 27776152
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of Serum microRNAs in Patients with Diabetic Kidney Disease: A Nested Case-Controlled Study and Bioinformatics Analysis.
Regmi A; Liu G; Zhong X; Hu S; Ma R; Gou L; Zafar MI; Chen L
Med Sci Monit; 2019 Mar; 25():1699-1708. PubMed ID: 30835718
[TBL] [Abstract][Full Text] [Related]
7. Uromodulin mRNA from Urinary Extracellular Vesicles Correlate to Kidney Function Decline in Type 2 Diabetes Mellitus.
Yamamoto CM; Murakami T; Oakes ML; Mitsuhashi M; Kelly C; Henry RR; Sharma K
Am J Nephrol; 2018; 47(5):283-291. PubMed ID: 29779026
[TBL] [Abstract][Full Text] [Related]
8. Association of Serum PSP/REG Iα with Renal Function in Pregnant Women.
Zhu X; Dong B; Reding T; Peng Y; Lin H; Zhi M; Han M; Graf R; Li L
Biomed Res Int; 2019; 2019():6970890. PubMed ID: 31139647
[TBL] [Abstract][Full Text] [Related]
9. Pancreatic stone protein predicts positive sputum bacteriology in exacerbations of COPD.
Scherr A; Graf R; Bain M; Christ-Crain M; Müller B; Tamm M; Stolz D
Chest; 2013 Feb; 143(2):379-387. PubMed ID: 22922487
[TBL] [Abstract][Full Text] [Related]
10. Pancreatic stone protein is highly increased during posttraumatic sepsis and activates neutrophil granulocytes.
Keel M; Härter L; Reding T; Sun LK; Hersberger M; Seifert B; Bimmler D; Graf R
Crit Care Med; 2009 May; 37(5):1642-8. PubMed ID: 19325491
[TBL] [Abstract][Full Text] [Related]
11. Serum Human Epididymis Protein 4 is Associated with Renal Function and Diabetic Kidney Disease in Patients with Type 2 Diabetes Mellitus.
Zhang M; Zhao B; Xie J; Liang Y; Yang Z
Biomed Res Int; 2019; 2019():4831459. PubMed ID: 31815140
[TBL] [Abstract][Full Text] [Related]
12. [Value of pancreatic stone protein/regenerating protein in severity evaluation and prognosis prediction for children with sepsis].
Peng HY; Zhu YM; Zhang XP; Kang XY
Zhongguo Dang Dai Er Ke Za Zhi; 2015 Nov; 17(11):1183-8. PubMed ID: 26575875
[TBL] [Abstract][Full Text] [Related]
13. Association of Glomerular Complement C4c Deposition With the Progression of Diabetic Kidney Disease in Patients With Type 2 Diabetes.
Duan S; Sun L; Nie G; Chen J; Zhang C; Zhu H; Huang Z; Qian J; Zhao X; Xing C; Zhang B; Yuan Y
Front Immunol; 2020; 11():2073. PubMed ID: 32983156
[No Abstract] [Full Text] [Related]
14. Diagnostic value of quantitative contrast-enhanced ultrasound (CEUS) for early detection of renal hyperperfusion in diabetic kidney disease.
Wang L; Wu J; Cheng JF; Liu XY; Ma F; Guo LH; Xu JM; Wu T; Mohan C; Peng A; Xu HX; Song YX
J Nephrol; 2015 Dec; 28(6):669-78. PubMed ID: 25712236
[TBL] [Abstract][Full Text] [Related]
15. Development and internal validation of machine learning algorithms for end-stage renal disease risk prediction model of people with type 2 diabetes mellitus and diabetic kidney disease.
Zou Y; Zhao L; Zhang J; Wang Y; Wu Y; Ren H; Wang T; Zhang R; Wang J; Zhao Y; Qin C; Xu H; Li L; Chai Z; Cooper ME; Tong N; Liu F
Ren Fail; 2022 Dec; 44(1):562-570. PubMed ID: 35373711
[TBL] [Abstract][Full Text] [Related]
16. Expression of Urokinase-type Plasminogen Activator Receptor and its Soluble Form in Type 2 Diabetic Kidney Disease.
Zhou Y; Ren J; Li P; Ma R; Zhou M; Zhang N; Kong X; Hu Z; Xiao X
Arch Med Res; 2019 Jul; 50(5):249-256. PubMed ID: 31593848
[TBL] [Abstract][Full Text] [Related]
17. Determinants of visfatin in type 2 diabetes patients with diabetic kidney disease: Relationship to inflammation, adiposity and undercarboxylated osteocalcin.
Kacso AC; Bondor CI; Coman AL; Potra AR; Georgescu CE
Scand J Clin Lab Invest; 2016; 76(3):217-25. PubMed ID: 26922969
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic value of serum cathepsin S in type 2 diabetic kidney disease.
Ren X; Wang W; Cao H; Shao F
Front Endocrinol (Lausanne); 2023; 14():1180338. PubMed ID: 37305031
[TBL] [Abstract][Full Text] [Related]
19. Circulating asprosin levels are increased in patients with type 2 diabetes and associated with early-stage diabetic kidney disease.
Zhang H; Hu W; Zhang G
Int Urol Nephrol; 2020 Aug; 52(8):1517-1522. PubMed ID: 32458209
[TBL] [Abstract][Full Text] [Related]
20. Circulating Expression Level of LncRNA Malat1 in Diabetic Kidney Disease Patients and Its Clinical Significance.
Zhou LJ; Yang DW; Ou LN; Guo XR; Wu BL
J Diabetes Res; 2020; 2020():4729019. PubMed ID: 32832561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
